Blockchain has become a popular topic lately, but Paul Mampilly thinks that people aren’t considering the scope of possible applications. It can store information securely in a way that is almost impossible to hack. One of the industries that has been looking into implementing blockchain is medicine. There are many different possibilities that are being considered.
It can be difficult and invasive to figure out if the prescriptions that you are taking are working as effectively as they should be. What if you could take a pill that could give you the information you are looking for without having to have blood drawn or collect other types of samples. Paul Mampilly sees this happening in near future by using pills equipped with advanced sensors.
The pill could collect the information and send it to an app for you and your doctors to view. Besides tracking the chemicals to see if your medication is working, they may have other uses as well. Doctors will be able to track if a patient is forgetting to take medication regularly, or if they are taking too much.
While a lot of people may think this sounds too far-fetched to actually work, Paul Mampilly says similar technology is already being used. The creators of Abilify have added a sensor to some of their pills that will allow doctors to see if they have actually been taken or not. Abilify is used to treat various mental health disorders.
Paul Mampilly has a lot of experience on Wall Street and has a knack for feeling out the market. Currently, he manages companies that are dedicated to helping others with investing and trading. After graduating in 1996 with an MBA from Fordham University, his career has brought him to positions in some of the biggest financial companies in the world.
Profits Unlimited was created by Paul Mampilly to help keep his readers up to date with the latest investment opportunities. While he may have retired, he is still busy working in his new endeavors. In addition to Profits Unlimited, he also acts as a Banyan Hill Publishing editor.
Read More : www.talkmarkets.com/contributor/Paul-Mampilly/